Mead Johnson won a unanimous jury verdict in the Inman case in the US District Court for the Northern District of Illinois, the company said Monday.
The case was the first bellwether trial against Mead Johnson in federal multidistrict litigation over allegations concerning the cause of necrotizing enterocolitis, or NEC, a serious gastrointestinal condition that primarily affects premature infants.
Mead Johnson said there are currently no outstanding jury verdicts against the company in the broader NEC litigation, citing favorable outcomes in the Collins and Whitfield state cases and the Illinois Appellate Court's reversal of the Watson decision.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.